Gut Microbial Changes Associated With Obesity in Youth With Type 1 DiabetesOriginal paper
What was studied?
This study examined whether gut microbiome composition and microbial metabolite profiles differ between lean and obese youth with type 1 diabetes (T1D). Researchers used metagenomic shotgun sequencing of stool samples to characterize bacterial community structure and taxa abundance. They also measured short-chain fatty acids (SCFAs) as microbial metabolite outputs. The goal was to describe obesity-associated gut microbial changes in a T1D population, a group already at elevated risk for complications.
Who was studied?
The pilot study included T1D youth divided into a lean group (BMI 5th to under 85th percentile, n = 27) and an obese group (BMI at or above the 95th percentile, n = 21). Participants had a mean age of 15.3 years, mean glycated hemoglobin A1c of 7.8%, and mean diabetes duration of 5.1 years. The combined sample was 42.0% female and 94.0% White.
What were the most important findings?
Bacterial community composition (beta-diversity) differed significantly between BMI groups. The obese group showed a significantly higher ratio of Prevotella to Bacteroides and increased relative abundance of Prevotella copri, along with other taxa that differed between lean and obese groups. Functional profiling also revealed upregulation of branched-chain amino acid (BCAA) biosynthesis pathways in the obese group, pointing to a metabolic signature accompanying the taxonomic shifts.
What are the greatest implications of this study?
These findings suggest that obesity in T1D youth is accompanied by measurable, structured changes in gut microbial ecology and function, not just body composition differences. The Prevotella to Bacteroides shift and BCAA biosynthesis upregulation echo patterns reported in obesity research more broadly, raising the possibility of shared microbial mechanisms across metabolic conditions. Because this was a pilot study, the findings support further investigation into the gut microbiome as a potential contributor to, or biomarker for, obesity-related complications in T1D.